RUA Life Sciences (LON:RUA) Stock Price Up 2.1% – Time to Buy?

RUA Life Sciences plc (LON:RUAGet Free Report) shares were up 2.1% during trading on Monday . The company traded as high as GBX 12 ($0.15) and last traded at GBX 12 ($0.15). Approximately 25,432 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 243,376 shares. The stock had previously closed at GBX 11.75 ($0.15).

RUA Life Sciences Stock Up 5.5 %

The firm has a 50 day moving average price of GBX 11.39 and a 200-day moving average price of GBX 11.68. The firm has a market cap of £8.02 million, a price-to-earnings ratio of -323.13 and a beta of 1.21. The company has a debt-to-equity ratio of 5.42, a current ratio of 9.01 and a quick ratio of 7.32.

RUA Life Sciences (LON:RUAGet Free Report) last issued its earnings results on Wednesday, December 11th. The company reported GBX 1.03 ($0.01) earnings per share (EPS) for the quarter. RUA Life Sciences had a negative net margin of 65.72% and a negative return on equity of 24.27%.

About RUA Life Sciences

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Further Reading

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.